Siglec-9 + tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer.
Yiying WangMengdi HeChen ZhangKankan CaoGuodong ZhangMoran YangYan HuangWei JiangHaiou LiuPublished in: Journal for immunotherapy of cancer (2023)
TAMs as a therapeutic target is worth further exploration.
Keyphrases